Primary Biliary Cirrhosis (Pbc) Treatment Market By Drug Type (Ursodeoxycholic Acid, Obeticholic Acid, Corticosteroids, Methotrexate); By Surgery (Liver Transplant); By Diagnosis Test (Blood Test, Imaging, Liver Biopsy) & By Geography - Forecast(2018 - 2023)

Report Code: HCR 0256 Report Format: PDF + Excel (Delivery in 48 Hrs)
Primary biliary cirrhosis, also known as primary biliary cholangitis (PBC), is an autoimmune disease of the liver which is relatively rare as compared to other gastro diseases. The advanced stage of PBC is considered as cirrhosis. Identification, diagnosis and treatment differ based on the severity of PBC and patients’ condition. Several diagnosis tests are recommended including blood tests, imaging tests and liver biopsy which further encompass several test methods. The treatment includes medication approach as well as surgical approach. Medical approach includes employment of approved drugs individually or in combination including Ursodeoxycholic Acid, Corticosteroids and Methotrexate which are marketed under different brand names. Obeticholic Acid, new drug is under clinical trials and is expected to be launched in the near future.

The growth of this market is primarily attributed to increasing availability of treatment services and drugs. In addition, to drugs, liver transplantation is performed which completely prevents PBC. Establishment of diagnosis and treatment standards in the recent years boosts the overall service experience as well as treatment outcomes which propels the market growth. Driven by the aforementioned factors, this market is set to reach $XX billion by 2021, growing at a CAGR of XX% during 2016-2021.

Primary Biliary Cirrhosis Market

North America held a major share of XX% in the PBC drugs market, followed by Europe and APAC. Commercialization of new drugs and expanding specialized services for liver in India and China is set to boost the market revenue in APAC region.

The key players in the PBC Drugs market include:
  • Sanofi S.A.
  • Intercept Pharmaceuticals, Inc.
  • Mylan N.V.
  • Mankind Pharmaceuticals Pvt. Ltd.

The estimates and forecasts have been derived based on various inputs from primary and secondary sources. Secondary sources such as articles, whitepapers, journals and other has helped to deliver an extensive analysis in this report. Insights related to various regulatory frameworks and clinical studies have been collected from publications by health regulatory agencies. To enhance the accuracy of the estimates, the data has been validated by conducting interviews with industry experts. This report on the PBC treatment market identifies many such insights, new product developments, besides providing a detailed analysis of the key drug companies, treatment service providers and growth potential of the market.
1. Primary Biliary Cirrhosis (Pbc) Treatment Market - Overview
1.1. Definitions and Scope
2. Primary Biliary Cirrhosis (Pbc) Treatment Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Primary Biliary Cirrhosis (Pbc) Treatment Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Primary Biliary Cirrhosis (Pbc) Treatment Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Primary Biliary Cirrhosis (Pbc) Treatment Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Primary Biliary Cirrhosis (Pbc) Treatment Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Primary Biliary Cirrhosis (Pbc) Treatment Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Primary Biliary Cirrhosis (Pbc) Treatment Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Ursodeoxycholic Acid
8.3.2. Obeticholic Acid
8.3.3. Corticosteroids
8.3.4. Methotrexate
9. Primary Biliary Cirrhosis (Pbc) Diagnosis Tests Market- By Type (Market Size -$Million / $Billion)
9.1. Blood Tests
9.1.1. AMA Test
9.1.2. ALT Test 
9.1.3. AST Test
9.1.4. ALP Test
9.1.5. Others
9.2. Imaging Tests
9.2.1. Ultrasound
9.2.2. CT Scan
9.2.3. MRI
9.2.4. Others
9.3. Liver Biopsy
10. Primary Biliary Cirrhosis (Pbc) Treatment - By Geography (Market Size -$Million / $Billion)
10.1. Primary Biliary Cirrhosis (Pbc) Treatment Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Primary Biliary Cirrhosis (Pbc) Treatment - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Primary Biliary Cirrhosis (Pbc) Treatment - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Primary Biliary Cirrhosis (Pbc) Treatment – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Primary Biliary Cirrhosis (Pbc) Treatment Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Primary Biliary Cirrhosis (Pbc) Treatment Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Primary Biliary Cirrhosis (Pbc) Treatment Market – Key Company List by Country Premium
14. Primary Biliary Cirrhosis (Pbc) Treatment Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Mankind Pharmaceuticals Pvt. Ltd.
14.3. Solvay Pharma India Pvt Ltd
14.4. Zydus Pharmaceuticals
14.5. Mylan N.V.
14.6. Hexal AG
14.7. Sanofi S.A.
14.8. Sigma Pharmaceuticals Ltd
14.9. Intercept Pharmaceuticals, Inc.
14.10. Teva Pharmaceuticals Industries Ltd
14.11. FF Pharma
14.12. Company 11
14.13. Company 12
14.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Primary Biliary Cirrhosis (Pbc) Treatment Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Primary Biliary Cirrhosis (Pbc) Treatment Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables:

Table 1: Primary Biliary Cirrhosis (Pbc) Treatment Market Overview 2019-2024
Table 2: Primary Biliary Cirrhosis (Pbc) Treatment Market Leader Analysis 2018-2019 (US$)
Table 3: Primary Biliary Cirrhosis (Pbc) Treatment Market Product Analysis 2018-2019 (US$)
Table 4: Primary Biliary Cirrhosis (Pbc) Treatment Market End User Analysis 2018-2019 (US$)
Table 5: Primary Biliary Cirrhosis (Pbc) Treatment Market Patent Analysis 2013-2018* (US$)
Table 6: Primary Biliary Cirrhosis (Pbc) Treatment Market Financial Analysis 2018-2019 (US$)
Table 7: Primary Biliary Cirrhosis (Pbc) Treatment Market Driver Analysis 2018-2019 (US$)
Table 8: Primary Biliary Cirrhosis (Pbc) Treatment Market Challenges Analysis 2018-2019 (US$)
Table 9: Primary Biliary Cirrhosis (Pbc) Treatment Market Constraint Analysis 2018-2019 (US$)
Table 10: Primary Biliary Cirrhosis (Pbc) Treatment Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Primary Biliary Cirrhosis (Pbc) Treatment Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Primary Biliary Cirrhosis (Pbc) Treatment Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Primary Biliary Cirrhosis (Pbc) Treatment Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Primary Biliary Cirrhosis (Pbc) Treatment Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Primary Biliary Cirrhosis (Pbc) Treatment Market Value Chain Analysis 2018-2019 (US$)
Table 16: Primary Biliary Cirrhosis (Pbc) Treatment Market Pricing Analysis 2019-2024 (US$)
Table 17: Primary Biliary Cirrhosis (Pbc) Treatment Market Opportunities Analysis 2019-2024 (US$)
Table 18: Primary Biliary Cirrhosis (Pbc) Treatment Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Primary Biliary Cirrhosis (Pbc) Treatment Market Supplier Analysis 2018-2019 (US$)
Table 20: Primary Biliary Cirrhosis (Pbc) Treatment Market Distributor Analysis 2018-2019 (US$)
Table 21: Primary Biliary Cirrhosis (Pbc) Treatment Market Trend Analysis 2018-2019 (US$)
Table 22: Primary Biliary Cirrhosis (Pbc) Treatment Market Size 2018 (US$)
Table 23: Primary Biliary Cirrhosis (Pbc) Treatment Market Forecast Analysis 2019-2024 (US$)
Table 24: Primary Biliary Cirrhosis (Pbc) Treatment Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Ursodeoxycholic Acid, 2019-2024 ($)
Table 27: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Obeticholic Acid, 2019-2024 ($)
Table 28: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Corticosteroids, 2019-2024 ($)
Table 29: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Methotrexate, 2019-2024 ($)
Table 30: Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 31: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Blood Tests, 2019-2024 ($)
Table 32: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Imaging Tests, 2019-2024 ($)
Table 33: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Liver Biopsy, 2019-2024 ($)
Table 34: North America Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 35: North America Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 36: South america Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 37: South america Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 38: Europe Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 39: Europe Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 40: APAC Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 41: APAC Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 42: Middle East & Africa Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 43: Middle East & Africa Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 44: Russia Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 45: Russia Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 46: Israel Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 47: Israel Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 48: Top Companies 2018 (US$)Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume
Table 49: Product Launch 2018-2019Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume
Table 50: Mergers & Acquistions 2018-2019Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Primary Biliary Cirrhosis (Pbc) Treatment Market 2019-2024
Figure 2: Market Share Analysis for Primary Biliary Cirrhosis (Pbc) Treatment Market 2018 (US$)
Figure 3: Product Comparison in Primary Biliary Cirrhosis (Pbc) Treatment Market 2018-2019 (US$)
Figure 4: End User Profile for Primary Biliary Cirrhosis (Pbc) Treatment Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Primary Biliary Cirrhosis (Pbc) Treatment Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Primary Biliary Cirrhosis (Pbc) Treatment Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Primary Biliary Cirrhosis (Pbc) Treatment Market 2018-2019
Figure 8: Ecosystem Analysis in Primary Biliary Cirrhosis (Pbc) Treatment Market 2018
Figure 9: Average Selling Price in Primary Biliary Cirrhosis (Pbc) Treatment Market 2019-2024
Figure 10: Top Opportunites in Primary Biliary Cirrhosis (Pbc) Treatment Market 2018-2019
Figure 11: Market Life Cycle Analysis in Primary Biliary Cirrhosis (Pbc) Treatment Market
Figure 12: GlobalBy TypePrimary Biliary Cirrhosis (Pbc) Treatment Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy TypePrimary Biliary Cirrhosis (Pbc) Treatment Market Revenue, 2019-2024 ($)
Figure 14: Global Primary Biliary Cirrhosis (Pbc) Treatment Market - By Geography
Figure 15: Global Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Primary Biliary Cirrhosis (Pbc) Treatment Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 18: US Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 93: China Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Primary Biliary Cirrhosis (Pbc) Treatment Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Primary Biliary Cirrhosis (Pbc) Treatment Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Primary Biliary Cirrhosis (Pbc) Treatment Market
Figure 131: Developments, 2018-2019*Primary Biliary Cirrhosis (Pbc) Treatment Market
Figure 132: Company 1 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2018 (%)